Dear Colleagues,
it is our pleasure to announce we are now organizing Melanoma and Immunotherapy Bridge 2024.
Upcoming annual appointments for worldwide cancer clinicians and researchers, gaining more and more attendees every year, the 10 edition of Immunotherapy Bridge and the 15 edition of Melanoma Bridge will take place in Naples (Italy) from December 4th to 5th and from December 5th to 7th, respectively.
The 2024 editions will be very thrilling and an opportunity to increase even more the interactive atmosphere and the international attendance.
The scientific program of Immunotherapy Bridge will start with a Session jointly organized with SITC.
Hence, we will discuss the state of the art of immunotherapy beyond T cells and the organic specific immune response to share what different cancers teach about the general understanding of malignancies. The final session will be focused on neoadjuvant therapies.
The scientific program of Melanoma Bridge will host a very actual Session on the translational research in neoadjuvant therapy in Melanoma.
Then two Sessions dedicated to melanoma tumor biology and emergent strategies.
Immunotherapy and Melanoma Bridge will end with the Great Debate Sessions, in which the most important issues from clinical practice and research will be shown and exhaustively discussed from two different points of view.
Attendees are expected from all around the world and encouraged to submit their abstracts for poster or oral presentation during the Congresses.
We’re looking forward to meeting you again in Naples!
Paolo A. Ascierto
Corrado Caracò
Leisha A. Emens
Bernard A. Fox
Iman Osman
Igor Puzanov
The Immunotherapy Bridge will start with a Session jointly organized with SITC on TIL Advancements, CAR-T and TILs.
Hence, we will discuss the state of the art of immunotherapy beyond T cells, novel approches for immune monitoring and the organ specific immune response to share what different cancers teach about the general understanding of malignancies. The final session will be focused on neoadjuvant therapies across cancers.
Immunotherapy Bridge will end with the Great Debate Sessions, in which the most important issues from clinical practice and research will be shown and exhaustively discussed from two different points of view.
This year latest findings in melanoma research and advances on themes of paramount importance for melanoma prevention, diagnosis and treatment will be discussed in the sessions dedicated to the translational research in melanoma, tumor biology, melanoma brain metastases and emergent strategies on the progresses of melanoma research on biomarkers/precision medicine and on combination strategies.
Then, the Great Debate sessions, where counterpoint views from leading experts on specific and very actual controversial clinical issues will be presented and discussed from different points of view.
